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a b s t r a c t
Background:Non-traumatic subarachnoid haemorrhage (SAH) is a devastating disorder and in themajor-
ityof cases it is causedby ruptureof an intracranial aneurysm.Noactualdataareavailableon the incidence
of non-traumatic SAHand aneursymal SAH (aSAH) in theNetherlands and little is knownabout treatment
patterns of aSAH. Our purposewas therefore to assess the incidence, treatment patterns, and case-fatality
of non-traumatic (a)SAH within the Dutch general population.
Methods: Two population based data sources were used for this retrospective cohort study. One was
the nationwide hospital discharge registry (National Medical Registration, LMR). Cases were patients
hospitalized for SAH (ICD-9-code 430) in 2001–2005. The second source was the Integrated Primary
Care Information (IPCI) database, a medical record database allowing for case validation. Cases were
patientswith validated non-traumatic (a)SAH in 1996–2006. Incidence, treatment, and case-fatalitywere
assessed.
Results: The incidence rate (IR) of non-traumatic SAH was 7.12 per 100,000 PY (95%CI: 6.94–7.31) and
increased with age. The IR of aSAH was 3.78 (95%CI: 2.98–4.72). Women had a twofold increased risk
of non-traumatic SAH; this difference appeared after the fourth decade. Non-traumatic SAH fatality was
30% (95%CI: 29–31%). Of aSAH patients 64% (95%CI: 53–74%) were treated with a clipping procedure, and
26% (95%CI: 17–37%) with coiling.
ic SAH
ries.Conclusion: Non-traumat
are similar to other count
. Introduction
Non-traumatic subarachnoid haemorrhage (SAH) is a devastat-
ng event, with a case-fatality of around 30% [1,2]. Incidence rates
ave been assessed inmany countries and two patterns can be dis-
inguished: countrieswith high incidence of around 20 per 100,000
ersonyears (PY), suchas Finlandand Japan, andcountrieswith low
ncidence of approximately 5–10 per 100,000 PY [3].
Approximately 85% of non-traumatic SAH is a result of rupture
f an intracranial aneurysm (IA), although it is not clear whether
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Case-fatality is also similar as well as age and sex patterns in incidence.
© 2011 Elsevier B.V. 
this percentage is the sameoverdifferent age and sex categories [1].
Causes of spontaneous SAH from other origins include other vascu-
lar lesions, inﬂammatory and non-inﬂammatory lesions, tumours,
and drug or substance use [1,4].
The diagnosis of SAH is primarily based on CT imaging and
lumbar puncture, eventually followed by angiography; not only to
identify an aneurysm as potential cause of the haemorrhage, but
also to study theanatomical andmorphological conﬁgurationof the
aneurysm in relation to adjoining arteries, which allows for opti-
mal treatment selection [1]. Treatment of aneurysmal SAH (aSAH)
consists mainly of either neurosurgical clipping or endovascular
coiling. Other less frequently used treatment modalities comprise
Open access under the Elsevier OA license.wrapping, stenting, or balloon occlusion [5–7].
Given the fact that no recent data on age and sex speciﬁc inci-
dence of non-traumatic SAH and aSAH in the Netherlands are
available, we assessed the incidence of both conditions in the gen-
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reatment modalities applied to aSAH patients. This was done in
wopopulation based databases; a national discharge database and
smallermedical record databasewhich allowed for assessment of
he presence of an aneurysm and treatment modality.
. Materials and methods
.1. LMR database
Hospital discharge diagnoses were obtained from the national
egistry of hospital admissions, the National Medical Registration
LMR), containing information on all admissions in general and
cademic hospitals throughout the Netherlands (base population:
pproximately 16.5 million subjects). The International Classiﬁca-
ion of Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM)
as used to classify hospital admissions in the Netherlands dur-
ng the study period. Data used include hospital code, patient sex
nd age, ICD-9-CM coded discharge diagnosis, up to 9 diagnostic
r therapeutic procedures (coded according to the LMR Classiﬁca-
ion of Diagnostic, Therapeutic, and Surgical Acts), and discharge
estination (‘home’, ‘old people’s home’, ‘nursing home’, or ‘died in
ospital’).
Non-traumatic SAH cases were all admissions with a primary
ischarge diagnoses (ICD-9-CM) 430 (non-traumatic subarachnoid
aemorrhage) during the years 2001 through 2005. Case-fatality
as deﬁned as dying in the hospital during hospitalization for SAH.
The denominator for the incidence calculation was the annual
id-year population size as obtained from Statistics Netherlands
CBS, accessed through http://www.cbs.nl, as of June 7th, 2010).
.2. IPCI database
The Integrated Primary Care Information (IPCI) database is a
eneral practice research database with electronic medical record
ata currently comprisingmore than onemillion patients through-
ut theNetherlands. The patient population is representative of the
utch population regarding age and sex [8]. Details of the database
ave been described elsewhere [9]. The system complies with the
uropean Union guidelines on the use of medical data for research
nd has been proven valid for epidemiological studies [9]. The Sci-
ntiﬁc and Ethical Advisory Group of the IPCI project approved
he study (Project No. 07/02). The database allows for validation
f disease by requesting additional information from the general
ractitioner by questionnaire and copies of original specialist let-
ers.
Potential cases of non-traumatic SAH and aSAH were identi-
ed from the IPCI database using an extensive narrative search; we
dentiﬁed potential cases in the computerized records by search-
ng for International Classiﬁcation of Primary Care (ICPC) codes
f ‘cerebrovascular accident’ (K90), ‘other diseases of peripheral
rteries’ (K92), or ‘other diseases of the circulatory tract’ (K99), and
y free text searches on ‘intracranial’, ‘aneurysm’, ‘subarachnoid’,
haemorrhage’, or ‘nimodipine’. In the Netherlands, nimodipine is
xclusively prescribed as prophylaxis for delayed cerebral ischemia
fter aSAH.
To further validate the diagnosis of SAH, a short questionnaire
as mailed to the GPs. The questionnaire was used to conﬁrm
hether the person, according to the GP’s judgment, indeed suf-
ered from (aneurysmal) SAH, and whether the patient had been
een and diagnosed by a specialist. Copies of all specialist let-
ers were requested. Specialist letters usually provide information
bout history, physical examination, lumbar puncture, and reports
n imaging of the patient.
All caseswerevalidatedbymanual reviewof theelectronicmed-
cal record and subsequently by review of the questionnaires andNeurosurgery 113 (2011) 483–487
specialist letters that were obtained from the GP for each case. The
validity of the diagnosiswas judged by amedical doctor (R.R.) and a
neurologist (D.W.J.D. or F.K.). The judgment of the neurologist was
decisive. Case-fatality was deﬁned as dying within a period of 30
days after the date of onset of SAH (index date).
The denominator for the incidence calculation was the num-
ber of person years in the IPCI database during the study period
(January 1996–September 2006).
2.3. Statistical analysis
The incidence rate of non-traumatic SAH and aSAH was cal-
culated by dividing the number of incident cases (numerator), by
the total number of accrued person years (IPCI) or persons (LMR)
in the study population (denominator). Incidence rates (IR) were
calculated in age and sex categories. Conﬁdence intervals (95%
CI) for each estimate were based on the Poisson distribution. To
estimate case-fatality of aSAH in the IPCI database, Kaplan–Meier
survival analysis was used. Incidence rates were used to calculate
rate ratios of non-traumatic SAH and aSAH between females and
males. All analyses were performed using SPSS software version
15.0 (Chicago, Ill., USA).
2.4. Literature review
To compare our Dutch ﬁndings with the existing literature on
this topic, we performed a systematic review of the literature
from October 2005 onwards, adding to the review of De Rooij
and co-workers on the same topic, which ended in October 2005
[3]. A similar Medline search was used: (“Stroke”[Mesh] OR “Sub-
arachnoid Haemorrhage”[Mesh]) AND (“Epidemiology”[Mesh] OR
“Population”[Mesh] OR “Incidence”[Mesh]) for the time period
from October 2005 to May 2009. The papers thus obtained were
abstractedmanually by one researcher (R.R.). Our inclusion criteria
were: (1) study population is representative of the population in
general; and (2) for studies about stroke in general, SAH should be
considered as a separate entity.We excluded papers reporting inci-
dence rates in Finnish and Japanese populations, since these rates
are consistently higher than in other populations and therefore add
little to the comparison with our ﬁndings [1].
3. Results
3.1. LMR: non-traumatic SAH
In the period 2001–2005 a total of 5769 patients (64% female)
were admitted to Dutch hospitals with discharge diagnosis ‘non-
traumatic subarachnoid haemorrhage’. The overall nationwide
incidence rate of non-traumatic SAH was 7.12 per 100,000 per-
son years (PY) (95% CI: 6.94–7.31) (Table 1). The incidence rate
increased rapidly with age (Table 1, Fig. 1). The overall incidence
rate ratio (IRR) of non-traumatic SAH for women compared tomen
was 1.72 (95% CI: 1.63–1.81). This differential risk occurred grad-
ually and was most pronounced in the fourth and ﬁfth decade
(Table 1, Fig. 1). Case-fatality for non-traumatic SAH during hos-
pitalization was 30% (95% CI: 29–31%), and increased with age, but
did not differ between males and females (Table 1).
3.2. IPCI database: non-traumatic SAH and aSAH
In the initial source population of 488,118 persons, 107 incident
cases of non-traumatic SAH (70% female) were identiﬁed after val-
idation (Table 1). Based on these data the observed crude rate of
non-traumatic SAHwas 5.53 per 100,000 person years (PY) (95%CI:
4.56–6.66) (Table 1), which translates to a rate of 6.48 per 100,000
PY in the Netherlands after standardization to the Dutch age and
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Table 1
Incidence rates of SAH by age and sex in the LMR and IPCI databases.
LMR IR 95% CI Fatalitya IPCI IR 95% CI Fatalityb IPCI IR 95% CI Fatalityb
SAH cases (n) SAH cases (n) aSAH cases (n)
Age
<40 570 1.33 1.23–1.45 19.47 15 1.28 0.75–2.06 20 12 1.02 0.56–1.73 8.3
40–64 3305 12.2 11.79–12.62 23.84 69 12.14 9.53–15.3 20.5 49 8.62 6.46–11.3 4.2
65–79 1396 16.52 15.67–17.40 37.75 20 12.34 7.78–18.7 36.2 12 7.4 4.04–12.5 9.1
≥80 498 18.05 16.51–19.69 58.23 3 9.64 2.67–25.7 100 0 0
Sex
Female 3674 8.98 8.69–9.27 31.16 75 7.7 6.10–9.60 29.4 52 5.33 4.03–6.94 7.7
Male 2095 5.23 5.01–5.45 27.26 32 3.34 2.32–4.65 16.5 21 2.19 1.40–3.28 0
Male
<40 218 1 0.88–1.14 19.72 3 0.5 0.14–1.34 0 3 0.5 0.14–1.34 0
40–64 1218 8.9 8.41–9.41 21.35 21 7.4 4.71–11.09 10 15 5.28 3.09–8.49 0
65–79 527 13.81 12.67–15.03 36.05 8 11.78 5.56–22.23 41.7 3 4.42 1.22–11.8 0
≥80 132 15.26 12.82–18.03 59.09 0 0 0 0
Female
<40 352 1.68 1.51–1.86 19.32 12 2.09 1.14–3.54 25 9 1.57 0.78–2.86 11.1
40–64 2087 15.56 14.91–16.24 25.3 48 16.89 12.60–22.19 25.1 34 12 8.43–16.5 5.9
65–79 869 18.74 17.52–20.02 38.78 12 12.75 6.96–21.59 33.3 9 9.56 4.72–17.4 11.1



















lTotal 5769 7.12 6.94–7.31 29.75 107
a During hospitalization.
b Within 30 days, using Kaplan–Meier survival analysis.
ex distribution. The incidence rate increased with age and was
imilar to the LMR rates up until 64 years; rates were lower after
hat (Table 1).
In 68% of all IPCI derived non-traumatic SAH cases (n=73) an
neurysm had been diagnosed (95% CI: 59–76%). In our study, the
roportion of aneurysms as a cause of non-traumatic SAH seemed
o diminish with age, although the trend is not statistically signiﬁ-
ant (data not shown).
The crude observed incidence rate of aSAH in IPCI was 3.78 per
00,000 PY (95% CI: 2.98–4.72), which would imply a rate of 4.26
er 100,000 for theDutchpopulation (age and sex standardized). Of
hepatientswithananeurysmthemajoritywas treatedbymeansof
neurosurgical clipping procedure (64%, 95% CI: 53–74%) and 26%
95% CI: 17–37%) by means of endovascular coiling. Five patients
7%) did not receive any treatment because of rapid deterioration
nd death. In the remaining 3% we could not ﬁnd information on
rocedures.
Kaplan–Meier survival analysis showed that 26%of SAHpatients
ied within 30 days (95% CI: 17–34%) (Table 1). Case-fatality in
ig. 1. Sex Speciﬁc Incidence Rates of SAH in 5 year age bands in LMR data. Solid lines are
ine for men.4.56–6.66 25.5 73 3.78 2.98–4.72 5.6
aSAH patients was 5.6% (95% CI: 0.31–10.9) (Table 1). Risks could
not be estimated in separate treatment groups due to lownumbers.
3.3. Literature review
The Medline query yielded 866 papers. After screening on title
and abstract 48 studies remained for full text reading and ﬁnally
15 studies complied with the inclusion criteria. An overview of the
results from the studies is given in Table 2. Incidence rates var-
ied but in general remained below 10 per 100,000 PY. In almost
all studies a female preponderance was seen. Case fatality ranged
between 20 and 30%.
4. DiscussionWe used two different population based databases: a hospi-
tal discharge database and an electronic medical record database
to assess the occurrence, treatment, and case-fatality of non-
traumatic SAH and aSAH in the Netherlands. We used both sources
estimated rates, dashed lines the 95% conﬁdence bands; grey line for women, black
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Table 2
Published incidence rates of SAH, overall and in sex strata.
1st author Year All Female Male All
IR 95% CI IR 95% CI IR 95% CI Case-fatality 95% CI
De Rooij [3] 2007 9.1 8.8–9.5 – – – – – –
2007a 10.5 9.9–11.2 11.5 10.6–12.6 9.2 8.4–10.2 – –
Benatru [19] 2006 2.12f,g 1.04–3.21 – – – – 26.1c 10.6–55.5
Feigin [20] 2006 10 8.0–12.0 10 7.0–13 10 7.0–13 – –
Jiang [21] 2006 1.6d 0.8–4.1 1.5d 0.6–6.7 1.6d 0.6–6.5 – –
Johansen [22] 2006 9 – 10 – 6 – 27.5c 25.5–29.5b
Labovitz[23] 2006 9.7 7.5–12.0 10.4 – 9 – 26.0c 16–40b
Engberg [24] 2007 13.6 – – – – – 22.7e 19.8–25.8b
Kozak [25] 2007 27 26–28 33 32–35 20 19–21 26.7 25.2–28.3
Smeeton [26] 2007 6h 5.0–8.0 – – – – – –
Ishikawa [27] 2008 – – 54.4 – 25.6 – – –
Islam [28] 2008 7f 4.0–12.0 7 3.0–15 7 3.0–16 25c 0.5–49.5
Kofﬁjberg [17] 2008 12.4 12.2–12.6 14.4 14.2–14.7 10.3 12.2–12.6 31.7c 30.9–32.5b
Vaartjes [29] 2008 7.9b 7.4–8.3b 9.9 9.2–10 5.7 5.2–6.3 – –
EROS [30] 2009 – – 3.3g 0.7–9.2 4.8g 1.5–11.4 – –
Sridharan [31] 2009 4.2i 2.2–6.1 – – – – – –
a Subset of 18 studies, reporting incidences for men and women separately.
b Calculated from data in the article.
c Case-fatality within 28 days.
d Beijing population only.





































cf Most recent period only.
g Standardized to EU population.
h White population only.
i Age adjusted.
o proﬁt from the size in the LMR and the quality of information
nd validation opportunities in the IPCI database. By using these
ata we revealed various important observations: ﬁrst, the crude
ational incidence rate of non-traumatic SAHwas between 5 and 7
ases per 100,000 PY, putting the Netherlands in the low incidence
ountries. Second, about 70% of non-traumatic SAHwere of proven
neurysmal origin and thismight vary slightly by age (lower in high
ges). Third, case-fatality of non-traumatic SAH was high: around
6% within one month and this increased with age. Fourth, a strik-
ng age and gender pattern was observed in the incidence rates.
he incidence rates increased rapidly after age 40, butmostly so for
omen. Fifth, the incidence rates for aSAH increased less rapidly
ith age than for non-traumatic SAH overall, suggesting a differ-
nce in the percentage of aneurysms by age. Sixth the majority of
ersons with an aSAH underwent surgical clipping.
Our ﬁndings on the rates and case-fatality were similar to pre-
iously published population-based studies from other countries.
owever, often the rates for aSAH are not available. The assump-
ion that 85% of non-traumatic SAH is based on aneurysms, may
herefore not hold true in general and perhaps speciﬁcally not for
ll age categories. Some of the previous studies have investigated
ex speciﬁc rates and age–gender interaction, and also reported
igher rates inwomen; however the age dependent change in inci-
ence for women compared to men was reported few times. The
easons for the overall higher incidence inwomen are not clear, but
ormonal factors would be a ﬁrst logical option [10,11]. Our ﬁnd-
ng that the preponderance of women becomes evident around the
enopause, during which changes in oestrogen levels take place,
urther supports this suggestion. Previously, an increase in cardio-
ascular risk among women after menopause has been recognized
12], for which declining endogenous oestrogen levels have been
eld responsible [13]. Declining levels of oestrogen might lead to
mpaired activation of nitric oxide [14],which is hypothesized to be
n important factor in the aetiology of non-traumatic SAH through
ts effects on the vascular endothelium [15,16].
Beingbasedonobservationaldata the resultsof our studyshould
e interpreted in the light of potential limitations, such as selection
ias and information bias. Selection bias in assessment of rates and
ase-fatality is negligible in this study since we used populationbased databases. Selection may have occurred because validation
of the discharge diagnoses for the LMRwas done only in our hospi-
tal. Results of this validation may not be generalizable to all other
centres. Thus, the most important limitation is misclassiﬁcation of
the outcome. For a patient to be considered a case in our study, the
diagnosis non-traumatic SAH had to be made. Patients who died
before reaching medical care were not included in the LMR esti-
mate and it is highly likely that they were also missed in the IPCI
database due to lack of a proper diagnosis and specialist informa-
tion. Previous studies have estimated the percentage of persons
dying outside hospitals to be between 11 and 13% [17,18]. This
means that the true incidence is potentially 10% higher than in our
estimations (up to 8 per 100,000 PY). Another potential limitation
is the accuracy of the registered diagnosis in the LMR database.
Validation of discharge diagnoses in our own hospital showed that
10% of the cases were false positive; including perimesencephal
haemorrhage (data not shown). Inclusion of these false positive
cases in incidence estimates would lead to overestimation. In the
IPCI database, false positives were unlikely, since cases were val-
idated. In both databases false negative misclassiﬁcation has not
been quantiﬁed. We think it is limited in the IPCI database as we
applied a very sensitive search on codes and free text to identify
potential cases and reviewed all potential cases manually.
Misclassiﬁcation of mortality was an issue in the LMR database.
Since the database only captures data during hospitalizations and
is not linked to a death registry, it is not possible to obtain mor-
tality data of patients once they are discharged from the hospital.
We therefore chose to report on the mortality during hospital
admission only. Nonetheless, the case-fatality is comparable to the
case-fatality as estimated from the IPCI database that does cap-
ture follow-up and mortality data. This implies that most cases
die often within relatively short time and mostly during hospital-
ization. Case-fatality of aSAH patients is remarkably low and may
not represent true fatality of an aneurysmal SAH (Table 1). Severe
cases may have died before undergoing imaging; in that case an
aneurysmcould not be proven. Less severe caseswill probably have
survived the 30 day period.
The strength of this study is that two separate databases were


































[R. Risselada et al. / Clinical Neurolog
bservational and our study showed that they can be used com-
lementary. Discharge databases are large which allows for ﬁne
tratiﬁcation, but medical record databases allow for depth and
ore clinical insight. Together theyhaveprovided thorough insight
n the occurrence, case-fatality, and treatment of non-traumatic
a)SAH.
. Conclusion
In this study we showed non-traumatic SAH incidence in the
etherlands is in the range of the low-incidence countries. We
emonstrated that the incidence for both non-traumatic SAH and
he subgroup of aSAH depends highly on age and sex but the pat-
erns for aSAH might be slightly different than for non-traumatic
AH overall.
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